Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Sell
32
OMRNY Quote, Financials, Valuation and Earnings
Last price:
$28.04
Seasonality move
:
2.26%
Day range:
$27.42 - $29.45
52-week range:
$27.42 - $47.75
Dividend yield:
2.37%
P/E ratio:
175.39x
P/S ratio:
1.01x
P/B ratio:
1.10x
Volume:
40.6K
Avg. volume:
46.1K
1-year change:
-20.3%
Market cap:
$5.6B
Revenue:
$5.7B
EPS (TTM):
$0.16
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, OMRON has -- downside to fair value with a price target of -- per share.
OMRNY vs. S&P 500
-
Over the past 5 trading days, OMRON has underperformed the S&P 500 by -4.75% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
OMRON does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
OMRON revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter OMRON reported revenues of $1.3B.
Earnings Growth
-
OMRON earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter OMRON reported earnings per share of $0.35.
Enterprise value:
6.7B
EV / Invested capital:
--
Price / LTM sales:
1.01x
EV / EBIT:
29.65x
EV / Revenue:
1.21x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1,915.43x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
15.13x
Gross Profit (TTM):
$2.3B
Return On Assets:
0.39%
Net Income Margin (TTM):
0.58%
Return On Equity:
0.52%
Return On Invested Capital:
0.5%
Operating Margin:
8.43%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $6.4B | $6.1B | $5.5B | $1.4B | $1.3B | |
| Gross Profit | $2.9B | $2.6B | $2.3B | $583.4M | $601.3M | |
| Operating Income | $710.3M | $433.7M | $225.2M | $43.9M | $113.3M | |
| EBITDA | $907.2M | $640.8M | $441.3M | $101.1M | $166.7M | |
| Diluted EPS | $2.56 | $1.19 | $0.16 | $0.06 | $0.35 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.4B | $4.6B | $3.6B | $3.7B | $3.5B | |
| Total Assets | $7.4B | $7.3B | $7.2B | $9.1B | $8.7B | |
| Current Liabilities | $1.3B | $1.4B | $1.4B | $2B | $1.5B | |
| Total Liabilities | $2B | $1.8B | $1.8B | $2.6B | $2.6B | |
| Total Equity | $5.5B | $5.5B | $5.4B | $6.5B | $6.1B | |
| Total Debt | -- | -- | -- | $714.2M | $900.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $600.6M | $395.9M | $311M | $252.3M | $95.3M | |
| Cash From Investing | -$1.3B | -$411.3M | -$742.2M | -$137.3M | -$206.5M | |
| Cash From Financing | -$263.7M | -$435.1M | $595.9M | -$32.1M | $143.8M | |
| Free Cash Flow | $303.5M | $62.5M | -$3.5M | $117.4M | -$10.8M | |
OMRNY
Sector
Market Cap
$5.6B
$83.5M
Price % of 52-Week High
59.49%
58.46%
Dividend Yield
2.37%
0%
Shareholder Yield
-0.75%
0.8%
1-Year Price Total Return
-20.3%
-19.05%
Beta (5-Year)
1.158
0.881
Dividend yield:
2.37%
Annualized payout:
$0.68
Payout ratio:
211.62%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$28.90
200-day SMA
Sell
Level
$35.49
Bollinger Bands (100)
Sell
Level
29.8 - 34.28
Chaikin Money Flow
Buy
Level
559.4K
20-day SMA
Sell
Level
$29.85
Relative Strength Index (RSI14)
Sell
Level
36.92
ADX Line
Sell
Level
15.16
Williams %R
Neutral
Level
-70.944
50-day SMA
Sell
Level
$30.84
MACD (12, 26)
Sell
Level
-0.66
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
3.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.1658)
Buy
CA Score
(Annual)
Level (0.621)
Buy
Beneish M-Score
(Annual)
Level (-2.6586)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (2.482)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Omron Corporation is an diversified industrials company, with businesses in the areas of industrial automation, healthcare, social systems, and electronic components. The industrial automation business offers automation control systems, motion/drives, sensors, and robotics. The social systems business provides automated ticket gates in train stations, ticket vending machines, as well as onboard driver monitoring service in mainly Japan. The company’s healthcare business offers blood pressure monitors, nebulizers, electrotherapy devices, thermometers, and others. The electronic/mechanical components business offers mainly switches, safety and control components, and relays. Omron was founded in 1933 and is headquartered in Kyoto, Japan.
Stock Forecast FAQ
In the current month, OMRNY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OMRNY average analyst price target in the past 3 months is --.
-
Where Will OMRON Stock Be In 1 Year?
According to analysts, the consensus estimate is that OMRON share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About OMRON?
Analysts are divided on their view about OMRON share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that OMRON is a Sell and believe this share price will rise from its current level to --.
-
What Is OMRON's Price Target?
The price target for OMRON over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is OMRNY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for OMRON is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of OMRNY?
You can purchase shares of OMRON via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase OMRON shares.
-
What Is The OMRON Share Price Today?
OMRON was last trading at $28.04 per share. This represents the most recent stock quote for OMRON. Yesterday, OMRON closed at $28.41 per share.
-
How To Buy OMRON Stock Online?
In order to purchase OMRON stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
43
MNPR alert for Apr 3
Monopar Therapeutics [MNPR] is down 6.96% over the past day.
Buy
75
BKTI alert for Apr 3
BK Technologies [BKTI] is down 9.62% over the past day.
Sell
34
SWTX alert for Apr 3
SpringWorks Therapeutics [SWTX] is down 5.74% over the past day.
